HomeCompareABT vs PBCT

ABT vs PBCT: Dividend Comparison 2026

ABT yields 2.36% · PBCT yields 68.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PBCT wins by $3.62M in total portfolio value
10 years
ABT
ABT
● Live price
2.36%
Share price
$101.89
Annual div
$2.40
5Y div CAGR
63.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$533.6K
Annual income
$328,772.04
Full ABT calculator →
PBCT
PBCT
● Live price
68.97%
Share price
$19.41
Annual div
$13.39
5Y div CAGR
7.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.15M
Annual income
$1,740,349.80
Full PBCT calculator →

Portfolio growth — ABT vs PBCT

📍 PBCT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABTPBCT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABT + PBCT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ABT pays
PBCT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABT
Annual income on $10K today (after 15% tax)
$200.23/yr
After 10yr DRIP, annual income (after tax)
$279,456.23/yr
PBCT
Annual income on $10K today (after 15% tax)
$5,862.71/yr
After 10yr DRIP, annual income (after tax)
$1,479,297.33/yr
At 15% tax rate, PBCT beats the other by $1,199,841.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABT + PBCT for your $10,000?

ABT: 50%PBCT: 50%
100% PBCT50/50100% ABT
Portfolio after 10yr
$2.34M
Annual income
$1,034,560.92/yr
Blended yield
44.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABT right now

ABT
Analyst Ratings
30
Buy
10
Hold
Consensus: Buy
Price Target
$137.67
+35.1% upside vs current
Range: $120.00 — $158.00
Altman Z
4.9
Piotroski
6/9
PBCT
Analyst Ratings
2
Buy
18
Hold
3
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABT buys
0
PBCT buys
0
No recent congressional trades found for ABT or PBCT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABTPBCT
Forward yield2.36%68.97%
Annual dividend / share$2.40$13.39
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR63.2%7.5%
Portfolio after 10y$533.6K$4.15M
Annual income after 10y$328,772.04$1,740,349.80
Total dividends collected$492.4K$3.79M
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold

Year-by-year: ABT vs PBCT ($10,000, DRIP)

YearABT PortfolioABT Income/yrPBCT PortfolioPBCT Income/yrGap
1← crossover$11,084$384.43$18,115$7,414.60$7.0KPBCT
2$12,510$649.94$32,877$13,494.02$20.4KPBCT
3$14,505$1,118.82$59,783$24,605.07$45.3KPBCT
4$17,499$1,978.53$108,919$44,951.07$91.4KPBCT
5$22,364$3,640.59$198,822$82,279.18$176.5KPBCT
6$31,026$7,096.70$363,636$150,895.63$332.6KPBCT
7$48,215$15,016.56$666,360$277,269.67$618.1KPBCT
8$87,182$35,592.30$1,223,474$510,469.01$1.14MPBCT
9$191,446$98,161.15$2,250,747$941,629.40$2.06MPBCT
10$533,619$328,772.04$4,148,649$1,740,349.80$3.62MPBCT

ABT vs PBCT: Complete Analysis 2026

ABTHealthcare

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Full ABT Calculator →

PBCTStock

People's United Financial, Inc. operates as the bank holding company for People's United Bank, National Association that provides commercial banking, retail banking, and wealth management services to individual, corporate, and municipal customers. The company offers commercial deposit products, commercial real estate lending, middle market and business banking, equipment financing, mortgage warehouse and asset-based lending, treasury management services, and capital market capabilities. It also provides consumer lending, including residential mortgage and home equity lending; and consumer deposit gathering services. In addition, the company offers brokerage, financial and investment advisory, investment management, life insurance, financial management and planning, and non-institutional trust services, as well as cash management, municipal banking, online banking, investment trading, and telephone banking services. As of March 04, 2022, it operated approximately 400 retail locations in Connecticut, New York, Massachusetts, Vermont, New Hampshire, and Maine. The company also operates 562 ATMs. People's United Financial, Inc. was founded in 1842 and is headquartered in Bridgeport, Connecticut. As of April 1, 2022, People's United Financial, Inc. operates as a subsidiary of M&T Bank Corporation.

Full PBCT Calculator →
📬

Get this ABT vs PBCT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABT vs SCHDABT vs JEPIABT vs OABT vs KOABT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.